Notice of final decisions to amend (or not amend) the current Poisons Standard, May 2020

This web publication constitutes a notice for the purposes of regulation 42ZCZS and regulation 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations). In accordance with regulations 42ZCZS and 42ZCZX, this notice publishes:

1. the decisions made by a delegate of the Secretary pursuant to regulations 42ZCZR and 42ZCZU;
2. the reasons for those final decisions; and
3. the date of effect of those decisions.

Contents

• 1 Final decisions made pursuant to regulation 42ZCZR – proposals referred to the November 2019 Advisory Committee on Medicines Schedule (ACMS #28)
  • 1.1. Final decision in relation to Sumatripan
  • 1.2. Final decision in relation to Zolmitriptan
  • 1.3. Final decision in relation to Mometasone
  • 1.4. Final decision in relation to calcifediol monohydrate
  • 1.5. Final decision in relation to Paracetamol (liquid formulations)
  • 1.6. Final decision in relation to Paracetamol + ibuprofen
  • 1.7. Final decision in relation to Hyoscine butylbromide
  • 1.8. Final decision in relation to Lidocaine
• 2 Final decisions made pursuant to regulation 42ZCZR – proposals referred to the November 2019 Joint Advisory Committee on Medicines and Chemicals Scheduling (ACCS-ACMS #23)
  • 2.1. Final decision in relation to Caffeine
  • 2.2. Final decision in relation to N-methyl-2-pyrrolidone (NMP)
• 3 Final decisions made pursuant to regulation 42ZCZR – proposals referred to the November 2019 Advisory Committee on Chemicals Scheduling (ACCS #26)
  • 3.1. Final decision in relation to Carbon monoxide
  • 3.2. Final decision in relation to Momfluorothrin
  • 3.3. Final decision in relation to Tetraniliprole
  • 3.4. Final decision in relation to Methiozolin
  • 3.5. Final decision in relation to Lambda-cyhalothrin
• 4 Final decision(s) (without interim decision) made pursuant to regulation 42ZCZU
  • 4.1. Final decision in relation to Acequinocyl
  • 4.2. Final decision in relation to Agrobacterium radiobacter (Rhizobium rhizogenes)
  • 4.3. Final decision in relation to Nonanoic acid
• 5 Notice of an amendment to the current Poisons Standard in relation to Modified-release (MR) paracetamol
  • 5.1. Decision in relation to modified-release (MR) paracetamol